Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Emyria Logo
Emyria Growth Score
20
CB Rank
192929
Heat Score
48
Emria is a data-backed drug development and care delivery company.
Founded
obfuscation
PublicPost-IPO Equity Perth, Western Australia, Australia11-50 emyria.com
Health Care
Pharmaceutical
Therapeutics
Overview

Emyria
Total Funding
obfuscation
Growth Score
20
Heat Score
48

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score20
-48 pts
in past quarter
Heat Score 48
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Emyria

CB Rank
192929
Emria is a data-backed drug development and care delivery company.
Founded
obfuscation
PublicPost-IPO Equity Perth, Western Australia, Australia11-50 emyria.com
Health Care
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Emyria Limited
Operating Status Active
Stock Symbol  ASX:EMD
Company Type For Profit
Founders  Adam James
About the Company
Emyria Limited is a data-backed clinical drug development and care delivery company focused on accelerating treatment development and improving patient care.
Phone Number 1300 436 363
Contact Email info@emyria.com
Predictions & Insights

Growth Insight

See this Growth Insight
Emyria is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Data-backed Drug Development Platform
A platform that uses data analytics to support drug development processes.
Care Delivery Solutions
Services that utilize data to improve patient care delivery and management.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
3
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Tenmile Logo
Tenmile
—
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
—
Tenmile Logo
Tenmile
—
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
—
Tenmile Logo
Tenmile
—
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
—
Tenmile Logo
Tenmile
—
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
—
Tenmile Logo
Tenmile
—
Post-IPO Equity - Emyria Logo
Post-IPO Equity - Emyria
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 3

Employee Profiles

News

News and Press

News•Mar 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

547
74.2%
 in past month

Active Website Tech Count

21Emyria is actively using 21 technologies for its website, according to BuiltWith. These include SSL by Default, SPF, and  DNSSEC.
Sub-Organizations
Frequently Asked Questions

Where is Emyria's headquarters? Emyria is located in Perth, Western Australia, Australia.Who invested in Emyria? Emyria has 4 investors including Tenmile and  Taylor Collison Ltd.When was the last funding round for Emyria? Emyria closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Emyria's competitors? Alternatives and possible competitors to Emyria may include Medable, Rivia, and  BizInt.How much funding has Emyria raised to date? Emyria has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|